Fetal Interventricular Septum Volume Evaluated by Three-Dimensional Ultrasound Using Spatiotemporal Image Correlation and Virtual Organ Computer-Aided Analysis in Fetuses From Pre-Gestational Diabetes Mellitus Pregnant Women
Abstract:BACKGROUND
To assess the interventricular septum (IVS) volume of fetuses from pre-gestational diabetes mellitus (DM) pregnant women by 3-dimensional ultrasound using spatiotemporal image correlation (STIC) and virtual organ computer-aided analysis (VOCAL) methods.
METHODS
This was a prospective cross-sectional study of 45 fetuses from pre-gestational DM and 45 fetuses from healthy pregnant women (controls). Only singleton pregnancies between 20 and 34 + 6 weeks of gesta… Show more
“…5 Several studies have shown that GDM is significantly associated with both morphological and functional changes in the fetal heart. [6][7][8][9][10] Though the true mechanism is still unclear, it has been demonstrated that fetal cardiac changes are partly caused by fetal hyperglycemia and hyperinsulinemia, which triggers fat and protein synthesis in myocardial cells. 11,12 Fetal myocardial changes may be observed in even cases with wellcontrolled GDM.…”
Objective To compare fetal and neonatal cardiac morphology in fetuses of mothers with gestational diabetes mellitus (GDM) with the controls Patients and methods Pregnant women at average risk of GDM underwent 100-g, 3-h-OGTT at 24–28 weeks of gestation for diagnosis of GDM. Both GDM group and the control group underwent fetal echocardiography at 32–36 weeks to assess cardiac dimensions. The neonates underwent echocardiography within 48 h after birth to assess cardiac morphology. Results A total of 154 pregnant women were recruited, including 60 in the GDM group and 94 in the control group. All of the study group were well controlled for GDM. Most baseline characteristics of both groups were comparable. All obstetric outcomes were not significantly different between the two groups. Morphological cardiac dimensions in the fetuses and newborns of both groups were also not significant different. Subgroup analysis in the study group showed no significantly different in cardiac morphology between the group with diet control and that of insulin control. Conclusion Fetal and neonatal cardiac morphologic changes among mothers with well-controlled GDM are not significantly different from those in the controls. It is possible that good control of maternal blood glucose can prevent fetal and neonatal cardiac abnormalities.
“…5 Several studies have shown that GDM is significantly associated with both morphological and functional changes in the fetal heart. [6][7][8][9][10] Though the true mechanism is still unclear, it has been demonstrated that fetal cardiac changes are partly caused by fetal hyperglycemia and hyperinsulinemia, which triggers fat and protein synthesis in myocardial cells. 11,12 Fetal myocardial changes may be observed in even cases with wellcontrolled GDM.…”
Objective To compare fetal and neonatal cardiac morphology in fetuses of mothers with gestational diabetes mellitus (GDM) with the controls Patients and methods Pregnant women at average risk of GDM underwent 100-g, 3-h-OGTT at 24–28 weeks of gestation for diagnosis of GDM. Both GDM group and the control group underwent fetal echocardiography at 32–36 weeks to assess cardiac dimensions. The neonates underwent echocardiography within 48 h after birth to assess cardiac morphology. Results A total of 154 pregnant women were recruited, including 60 in the GDM group and 94 in the control group. All of the study group were well controlled for GDM. Most baseline characteristics of both groups were comparable. All obstetric outcomes were not significantly different between the two groups. Morphological cardiac dimensions in the fetuses and newborns of both groups were also not significant different. Subgroup analysis in the study group showed no significantly different in cardiac morphology between the group with diet control and that of insulin control. Conclusion Fetal and neonatal cardiac morphologic changes among mothers with well-controlled GDM are not significantly different from those in the controls. It is possible that good control of maternal blood glucose can prevent fetal and neonatal cardiac abnormalities.
“… 19) 20) Bravo-Valenzuela et al 21) reported significantly smaller fetal left atrial volume in fetuses from pregestational DM women than healthy mothers. Melo Júnior et al 20) reported no significant difference in mean fetal myocardial volume between normal pregnant women and those with pregestational diabetes, whereas Edward Bravo-Valenzuela et al 22) showed the significantly higher fetal IVS volumes by 3D ultrasound with STIC with VOCAL methods in pregestational DM mothers than healthy mothers.…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.